• LAST PRICE
    9.9400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    9.4500/ 14
  • Ask / Lots
    10.5000/ 1
  • Open / Previous Close
    0.0000 / 9.9400
  • Day Range
    ---
  • 52 Week Range
    Low 6.8241
    High 48.5000
  • Volume
    110
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 9.98
TimeVolumeGLSI
09:32 ET8269.75
09:41 ET4009.88
09:43 ET1009.82
09:45 ET15449.753
09:50 ET5009.76
09:52 ET8369.65
10:01 ET1009.65
10:15 ET1009.91
10:21 ET2549.91
10:30 ET1929.84
10:44 ET7909.7985
10:55 ET1009.74
11:02 ET1009.75
11:18 ET2009.71
11:36 ET2009.8099
11:38 ET8009.78
11:40 ET2009.755
11:51 ET12009.8
11:54 ET2009.8399
11:56 ET14569.7905
12:02 ET1759.774
12:23 ET1009.815
12:30 ET2009.86
12:39 ET11009.91
12:52 ET40010.1223
12:54 ET89910.03
12:56 ET50010.0581
12:57 ET21610.1
01:06 ET30010.08
01:14 ET10310.0676
01:19 ET1009.9273
01:44 ET10010.04
01:46 ET20010.0031
01:51 ET3649.99
02:06 ET15010.05
02:13 ET10010.0245
02:44 ET10010.15
02:58 ET10010.09
03:18 ET3849.9951
03:20 ET10009.985
03:34 ET45349.91
03:41 ET3269.79
03:43 ET1009.85
03:48 ET2009.86
03:50 ET1509.86
03:56 ET2009.78
03:57 ET2009.78
03:59 ET17959.94
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLSI
Greenwich Lifesciences Inc
126.2M
-21.9x
---
United StatesCAPR
Capricor Therapeutics Inc
109.9M
-5.5x
---
United StatesSRZN
Surrozen Inc
103.0M
0.0x
---
United StatesPASG
Passage Bio Inc
108.9M
-0.6x
---
United StatesGALT
Galectin Therapeutics Inc
119.1M
-3.6x
---
United StatesIOBT
IO Biotech Inc
109.5M
0.0x
---
As of 2022-08-18

Company Information

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 will be delivered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce GP2 peptide-specific immunity. GP2 treatment is administered via an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. The Company's Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells while not affecting normal cells or to deliver certain immune system components to inhibit the spread of cancer.

Contact Information

Headquarters
3992 Bluebonnet Dr, Building 14STAFFORD, TX, United States 77477
Phone
203-434-3290
Fax
302-636-5454

Executives

Independent Chairman of the Board
David McWilliams
Chief Executive Officer, Chief Financial Officer, Director
Snehal Patel
Vice President - Clinical & Regulatory Affairs
Jaye Thompson
Chief Medical Officer, Director
F. Joseph Daugherty
Independent Director
Kenneth Hallock

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$126.2M
Revenue (TTM)
$0.00
Shares Outstanding
12.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.45
Book Value
$2.04
P/E Ratio
-21.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.